CULLINAN THERAPEUTICS INC CGEM
COM · Common Stock · CUSIP 230031106 · ISIN US2300311063
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersCambridge, MA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 43.5m as of 2021-04-30, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $41.47.
Biggest buyers
| MPM BIOIMPACT LLC | New | +7.9m |
| Foresite Capital Management V, LLC | New | +2.7m |
| CHI Advisors LLC | New | +2.2m |
| BAUPOST GROUP LLC/MA | New | +1.8m |
| FMR LLC | New | +1.2m |
| EVENTIDE ASSET MANAGEMENT, LLC | New | +1.2m |
| Venrock Adviser, LLC | New | +1.2m |
| VANGUARD GROUP INC | New | +1.2m |
| ORBIMED ADVISORS LLC | New | +1.1m |
| Rock Springs Capital Management LP | New | +1.1m |
Biggest sellers
| None |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| BIOTECHNOLOGY VALUE FUND L P 13G · passive investor no change · filed 2026-08-14 | 10.0% |
| Lynx1 Capital Management LP 13G · passive investor -4.7 pts · filed 2025-11-14 | 9.8% |
| PRICE T ROWE ASSOCIATES INC /MD/ 13G · institution new · filed 2026-08-14 | 6.2% |
| STATE STREET CORP 13G · institution new · filed 2026-08-07 | 6.0% |
| Kynam Capital Management, LP 13G · institution new · filed 2026-03-04 | 5.3% |
Fell to 5% or below in the last year: VANGUARD GROUP INC (0.0%, 2026-03-26)
Insider purchases and sales in Q1 2021
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q2 2019 | 0 | — | 0 | — | — |
| Q3 2019 | 0 | — | 0 | — | — |
| Q4 2019 | 0 | — | 0 | — | — |
| Q1 2020 | 0 | — | 0 | — | — |
| Q2 2020 | 0 | — | 0 | — | — |
| Q3 2020 | 0 | — | 0 | — | — |
| Q4 2020 | 0 | — | 0 | — | — |
| Q1 2021 | 4 | $10.6m | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2021-01-12 | GADICKE ANSBERT Director | Bought | $6.3m300.0k shares |
| 2021-01-12 | MPM Oncology Impact Management LP +3 10% owner | Bought | $6.3m300.0k shares |
| 2021-01-12 | Jovan-Embiricos Morana +8 Director · See Footnote | Bought | $4.2m200.0k shares |
| 2021-01-12 | Hughes Owen President and CEO, director | Bought | $52.5k2.5k shares |
| 2021-01-12 | Trigilio Jeffrey Chief Financial Officer | Bought | $47.2k2.2k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q1 2021
| Manager | Shares | Change |
|---|---|---|
| MPM BIOIMPACT LLC 41.43% of their portfolio | 7.9m $329.8m | New |
| Foresite Capital Management V, LLC 33.46% of their portfolio | 2.7m $113.8m | New |
| CHI Advisors LLC 18.37% of their portfolio | 2.2m $91.8m | New |
| BAUPOST GROUP LLC/MA 0.57% of their portfolio | 1.8m $71.7m | New |
| FMR LLC 0.00% of their portfolio | 1.2m $50.8m | New |
| EVENTIDE ASSET MANAGEMENT, LLC 0.73% of their portfolio | 1.2m $49.0m | New |
| Venrock Adviser, LLC 5.32% of their portfolio | 1.2m $49.0m | New |
| VANGUARD GROUP INC 0.00% of their portfolio | 1.2m $48.0m | New |
| ORBIMED ADVISORS LLC 0.03% of their portfolio | 1.1m $47.8m | New |
| Rock Springs Capital Management LP 0.98% of their portfolio | 1.1m $44.8m | New |
| Boxer Capital, LLC 1.52% of their portfolio | 1.1m $44.8m | New |
| BVF INC/IL 1.64% of their portfolio | 1.0m $43.7m | New |
| BlackRock Inc. 0.00% of their portfolio | 887.8k $37.0m | New |
| PRICE T ROWE ASSOCIATES INC /MD/ 0.00% of their portfolio | 723.6k $30.2m | New |
| Avidity Partners Management LP 0.82% of their portfolio | 707.4k $29.5m | New |
| Woodline Partners LP 0.50% of their portfolio | 542.9k $22.6m | New |
| FRANKLIN RESOURCES INC 0.01% of their portfolio | 488.3k $20.3m | New |
| Logos Global Management LP 1.68% of their portfolio | 413.5k $17.2m | New |
| MILLENNIUM MANAGEMENT LLC 0.02% of their portfolio | 403.8k $16.8m | New |
| RA CAPITAL MANAGEMENT, L.P. 0.22% of their portfolio | 350.0k $14.6m | New |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.03% of their portfolio | 341.7k $14.2m | New |
| Vivo Capital, LLC 0.37% of their portfolio | 250.0k $10.4m | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 220.3k $9.2m | New |
| PURA VIDA INVESTMENTS, LLC 0.62% of their portfolio | 216.6k $9.0m | New |
| STATE STREET CORP 0.00% of their portfolio | 194.8k $8.1m | New |
| JANUS HENDERSON GROUP PLC 0.00% of their portfolio | 173.5k $7.2m | New |
| WELLINGTON MANAGEMENT GROUP LLP 0.00% of their portfolio | 154.5k $6.4m | New |
| Cormorant Asset Management, LP 0.18% of their portfolio | 150.0k $6.2m | New |
| NORTHERN TRUST CORP 0.00% of their portfolio | 141.2k $5.9m | New |
| FARALLON CAPITAL MANAGEMENT, L.L.C. 0.03% of their portfolio | 125.0k $5.2m | Not comparable |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 111.3k $4.6m | New |
| Artal Group S.A. 0.09% of their portfolio | 100.0k $4.2m | New |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.00% of their portfolio | 86.4k $3.6m | New |
| D. E. Shaw & Co., Inc. 0.00% of their portfolio | 64.0k $2.7m | New |
| CANADA PENSION PLAN INVESTMENT BOARD 0.00% of their portfolio | 64.0k $2.7m | New |
| Birchview Capital, LP 1.49% of their portfolio | 60.1k $2.5m | New |
| CAAS CAPITAL MANAGEMENT LP 0.08% of their portfolio | 60.0k $2.5m | New |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 56.1k $2.3m | New |
| Nuveen Asset Management, LLC 0.00% of their portfolio | 49.7k $2.1m | New |
| Schonfeld Strategic Advisors LLC 0.03% of their portfolio | 48.4k $2.0m | New |
| J. Goldman & Co LP 0.11% of their portfolio | 42.5k $1.8m | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 38.2k $1.6m | New |
| Bank of New York Mellon Corp 0.00% of their portfolio | 34.8k $1.5m | New |
| VICTORY CAPITAL MANAGEMENT INC 0.00% of their portfolio | 34.7k $1.4m | Not comparable |
| Alyeska Investment Group, L.P. 0.01% of their portfolio | 25.0k $1.0m | Not comparable |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 23.3k $972.0k | New |
| Laurion Capital Management LP 0.01% of their portfolio | 21.0k $875.0k | New |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 0.00% of their portfolio | 19.8k $825.0k | New |
| TD Asset Management Inc 0.00% of their portfolio | 18.7k $781.0k | New |
| RHUMBLINE ADVISERS 0.00% of their portfolio | 11.6k $483.0k | New |
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 8.6k $358.0k | New |
| NEW YORK STATE COMMON RETIREMENT FUND 0.00% of their portfolio | 8.4k $350.0k | New |
| AMERICAN INTERNATIONAL GROUP, INC. 0.00% of their portfolio | 7.7k $319.0k | New |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE 0.00% of their portfolio | 7.4k $308.0k | New |
| PNC Financial Services Group, Inc. 0.00% of their portfolio | 7.4k $306.0k | New |
| MetLife Investment Management, LLC 0.00% of their portfolio | 6.1k $254.1k | New |
| VOYA INVESTMENT MANAGEMENT LLC 0.00% of their portfolio | 5.5k $228.0k | New |
| Ensign Peak Advisors, Inc 0.00% of their portfolio | 5.0k $208.0k | New |
| Metropolitan Life Insurance Co/NY 0.00% of their portfolio | 4.5k $185.7k | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 4.1k $171.0k | New |
| STRS OHIO 0.00% of their portfolio | 3.2k $133.0k | New |
| UBS Group AG 0.00% of their portfolio | 3.1k $129.0k | New |
| CITIGROUP INC 0.00% of their portfolio | 2.5k $103.0k | New |
| Legal & General Group Plc 0.00% of their portfolio | 1.4k $56.0k | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 1.3k $52.0k | New |
| Ameritas Investment Partners, Inc. 0.00% of their portfolio | 1.1k $45.0k | New |
| Ikarian Capital, LLC 0.01% of their portfolio | 1.0k $42.0k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 820 $34.0k | New |
| BANK OF MONTREAL /CAN/ 0.00% of their portfolio | 399 $14.0k | New |
| MORGAN STANLEY 0.00% of their portfolio | 385 $16.0k | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | New |